2017 BioTaiwan Highlights

BPM is a clinical-staged biotech company, focusing on developing novel biomarker-based diagnostics for chronic diseases and oncology.  BPM's first product, DNlite, has been shown more sensitive than the current standard tests for detecting the renal complication and predicting/monitoring the progression of DKD.